Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|September 28, 2018
A statistical method to convert published response rates into marginal distributions with an example application in psoriasisHelmut Petto, Ulrich Mrowietz, Stefan Wilhelm, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common ComparatorHelmut Petto, Zbigniew Kadziola, Alan Brnabic, et al.
The Journal of Sexual Medicine|November 15, 2006
Predictors of tadalafil efficacy in men with erectile dysfunction: the SURE study comparing two dosing regimensPierre Costa, Jacques Buvat, Simon Holmes, et al.
BMC Cardiovascular Disorders|November 2, 2014
Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stageLuis A Vázquez, Ángel Rodríguez, Javier Salvador, et al.
Joint Bone Spine|June 26, 2013
Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: results from the European Forsteo Observational StudyGerald Rajzbaum, Franck Grados, David Evans, et al.
Bone|November 15, 2012
High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosisChristian Graeff, Fernando Marin, Helmut Petto, et al.
The Journal of Dermatological Treatment|June 22, 2023
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitisJacob P Thyssen, Thomas Bieber, C Elise Kleyn, et al.
Bone|May 18, 2016
Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatmentAstrid Fahrleitner-Pammer, David Burr, Harald Dobnig, et al.
Diabetes Care|February 3, 2011
Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemiaBaptist Gallwitz, Michael Böhmer, Thomas Segiet, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 21, 2012
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE StudyStephan Matthaei, Matthew Reaney, Chantal Mathieu, et al.
Pageof 2